期刊文献+

生长激素缺乏症生化检测综合分析 被引量:12

Evaluation of the diagnostic value of biochemical tests in children with growth hormone deficiency
原文传递
导出
摘要 目的以临床诊断作为矮小症患儿(可疑GHD)诊断标准,评估生长激素激发试验、胰岛素样生长因子Ⅰ(IGFⅠ)及IGF结合蛋白3(IGFBP3)对GHD的诊断价值。方法放免方法检测84例可疑GHD患者及63例非GHD患者GH峰值、IGFⅠ及IGFBP3,运用ROC曲线方法选定各生化检测的最佳截定值,并计算各最佳截定值的敏感性(sensitivity,S)、特异性(specificity,Sp)及诊断有效率(diagnosticefficiency,DEf)。结果ROC曲线显示GH激发试验GH峰值7.65μg/L为最佳截定值,DEf达84.4%,S为75.9%,Sp达94.9%;IGFⅠSDS最佳截定值为-1.85,S为70.2%、Sp为83.1%、DEf为70.2%;IGFBP3SDS最佳截定值为-1.55,比传统-2SD高,DEf为64.3%,Sp较高(89.8%),但S仅为45.8%。联合使用上述3种测定有较佳的DEf(91.2%),S(89.3%)和Sp(93.7%)。结论GH激发试验如选取一个好的截定值(本研究为GH峰值7.65μg/L),则该试验对GHD具有较高诊断价值;单个IGFⅠ检测则逊于GH激发试验;IGFBP3单独诊断GHD价值不大。三者联合使用诊断率及准确率皆很高,最具诊断价值。 Objective To evaluate the diagnostic value of biochemical tests(GH stimulation tests, IGF-Ⅰ and IGFBP-3) in short children suspected with growth hormone deficiency (GHD). Methods The patients were divided into 2 groups : GHD group including 84 suspected GHD short children aged ( 10.8±1.9 ) years, in whom diagnosis of GHD was based on a medical history associated with typical phenotypic feature, and non-GHD group including 63 short children aged (10.6±2.7 )years, in whom GHD was not suspected. The receiver operating characteristic (ROC) plot analysis was used and sensitivity (S) , specificity (Sp) and diagnostic efficiency (DEf) of cut-off point were calculated. Results The ROC plot showed that the cut-off point for GH stimulation : ( 1 ) The peak value of GH was 7.65ng/ml with sensitivity (S) 75.9%, specificity (Sp) 94.9%, diagnostic efficiency ( DEf), 84.4% ; (2) IGF-Ⅰ SDS was -1.85 with S 70.2%, Sp 83.1%, DEf, 70.2% ; (3) The IGFBP-3 SDS was -1.55 with S 45.8% , Sp 89.8% , DEf, 64.3%. The joint use of these 3 laboratory assays showed higher S ( 89.3% ) , Sp(93.7% ) , and Def( 91.2% ). Conclusions Our findings support the need to define the best cut-off line for each laboratory assay for diagnosing GHD. Pharmaceutical stimulation test is more valuable than measurement of serum IGF-Ⅰ alone. Serum IGFBP-3 does not significantly contribute to the diagnosis of GHD. The joint use of these 3 laboratory assays seems to be most effective for GHD diagnosis with high value of DEf, S, and Sp.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2005年第4期341-343,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 生长激素缺乏症 生化检测 综合分析 矮小症 生长激素 小儿 Growth hormone deficiency Blood chemical analysis ROC curve
  • 相关文献

参考文献13

  • 1Shalet SM, Toogood A, Rahim A, et al. The diagnosis of growth hormone deficiency in children and adults. Endocrinol Rev, 1998,19:203-223.
  • 2Clemmons DR. The diagnostic use of insulin-like growth factor (IGF)-Ⅰ and IGF binding protein measurements in growth hormone deficiency. J Endocrinol Invest, 1998,21:105-110.
  • 3Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem, 1993,39:561-577.
  • 4Rosenfeld RG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab, 1995,80:1532-1540.
  • 5Tillman V, Buchler JMH, Kibirige MS, et al. Biochemical tests in the diagnosis of children growth hormone deficiency. J Clin Endocrinol Metab, 1997,82:531-535.
  • 6Cianfarani S, Boemi S, Spagnoll A, et al. Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency? Clin Endocrinol (Oxf), 1995,43:43-47.
  • 7Ranke MB, Schweizer R, Elmlinger MW, et al. Significance of basal IGF-Ⅰ, IGFBP-3 and IGFBP-2 measurement in the diagnostics of short stature in children. Horm Res, 2000,54:60-68.
  • 8Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. Serum insulin-like growth factor I in a random population sample of man and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin Endocrinol (Oxf), 1994,41:351-357.
  • 9Blum WF, Ranke MB, Keitzmann K, et al. A specific radio-immunoassay for the growth hormone (GH)-dependent so-matomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab, 1990,70:1292-1298.
  • 10Darendeliler F, Spinu I, Bas F, et al. Reevaluation of growth hormone deficiency during and after growth hormone (GH) treatment: diagnostic value of GH tests and IGF-Ⅰ and IGFBP-3 measurements. J Pediatr Endocrinol Metab, 2004,17:1007-1012.

二级参考文献9

  • 1李堂,杜嗣廉,林荣军.吡啶斯的明对生长激素缺乏症儿生长激素分泌的激发作用[J].实用儿科临床杂志,1996,11(2):83-84. 被引量:4
  • 2Rosenfeld NG, Albertsson-Wikland K, Cassorla F, et al. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab, 1995,80:1532-1540.
  • 3Tanner JM, Davies PSW. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr, 1985,107:317-329.
  • 4Ghigo E, Bellone J, Aimaretti G, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab, 1996,81:3323-3327.
  • 5Friend K, Iranmanesh A, Login IS, et al. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. Eur Endocrinol J, 1997,137:377-3
  • 6Shah A, Stanhope R, Matthews D. Harzards of pharmacological tests of growth hormone secretion in childhood. Br Med J, 1992,304:173-174.
  • 7Carel CJ, Tresca JP, Letrait M, et al. Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Endocrinol Metab, 1997,82:2117-2121.
  • 8Tillmann V, Buckler JMH, Kibirige MS, et al. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab, 1997,82:531-535.
  • 9王晓东,潘长玉.吡啶斯的明试验对评价垂体hGH储备功能的价值[J].中华内分泌代谢杂志,1990,6(4):201-202. 被引量:4

共引文献35

同被引文献180

引证文献12

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部